🇺🇸 FDA
Patent

US 9458132

Therapeutic compounds and compositions and their use as PKM2 modulators

granted A61PA61P35/00A61P43/00

Quick answer

US patent 9458132 (Therapeutic compounds and compositions and their use as PKM2 modulators) held by Agios Pharmaceuticals, Inc. expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P35/00, A61P43/00, A61P7/00, A61P7/06